Literature DB >> 19263033

Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus.

E M Horváth1, R Benko, L Kiss, M Murányi, T Pék, K Fekete, T Bárány, A Somlai, A Csordás, C Szabo.   

Abstract

AIM/HYPOTHESIS: Postpandrial hyperglycaemia is a significant risk factor for the development of macrovascular diseases. There is no clear agreement in the field whether these alterations result from hyperglycaemic episodes or from exaggerated alterations ('glycaemic swings') in blood glucose. We compared the effect of stable high glucose with a model of poorly maintained insulin-controlled diabetes (on average lower glucose, but with large glycaemic swings) on the development of endothelial dysfunction in rats.
METHODS: Intermediate- or long-acting insulin was used to reduce mean blood glucose levels. One group of animals had stable low glucose levels, while animals in the other group exhibited rapid changes ('swings') in their blood glucose concentration. Acetylcholine-induced endothelium-dependent vascular relaxation of the thoracic aorta was measured. Immunohistochemistry, western blot analysis and flow cytometry were used to determine nitrotyrosine formation and poly(ADP-ribose) accumulation in the aorta, in circulating leucocytes and in bone marrow cells.
RESULTS: Steady normalisation of blood glucose levels (a model of well-controlled diabetes) protected against the development of endothelial dysfunction, poly(ADP-ribose) polymerase (PARP) activation and nitrotyrosine production. However, impairment of endothelium-dependent relaxation was found in the animals undergoing glycaemic swings, even though the fructosamine levels in these animals were lower than in the untreated diabetic rats. This was associated with elevated PARP activation in the aorta and in bone marrow cells that was similar to or even more pronounced than that seen in the untreated diabetic animals. CONCLUSIONS/
INTERPRETATION: Large glycaemic swings exert deleterious cardiovascular effects in diabetes mellitus, in part via enhanced activation of the PARP pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263033     DOI: 10.1007/s00125-009-1304-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  45 in total

1.  Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction.

Authors:  Ludovica Piconi; Lisa Quagliaro; Roberta Assaloni; Roberto Da Ros; Amabile Maier; Gianni Zuodar; Antonio Ceriello
Journal:  Diabetes Metab Res Rev       Date:  2006 May-Jun       Impact factor: 4.876

2.  Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.

Authors:  Irina G Obrosova; Jon G Mabley; Zsuzsanna Zsengellér; Tamara Charniauskaya; Omorodola I Abatan; John T Groves; Csaba Szabó
Journal:  FASEB J       Date:  2004-12-20       Impact factor: 5.191

Review 3.  Advanced glycation end products: sparking the development of diabetic vascular injury.

Authors:  Alison Goldin; Joshua A Beckman; Ann Marie Schmidt; Mark A Creager
Journal:  Circulation       Date:  2006-08-08       Impact factor: 29.690

4.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.

Authors:  M Hanefeld; S Fischer; U Julius; J Schulze; U Schwanebeck; H Schmechel; H J Ziegelasch; J Lindner
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

5.  Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta.

Authors:  Kosuke Azuma; Ryuzo Kawamori; Yukiko Toyofuku; Yoshiro Kitahara; Fumihiko Sato; Tomoaki Shimizu; Kyoko Miura; Tomoyuki Mine; Yasushi Tanaka; Masako Mitsumata; Hirotaka Watada
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-03       Impact factor: 8.311

6.  Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase.

Authors:  F G Soriano; P Pacher; J Mabley; L Liaudet; C Szabó
Journal:  Circ Res       Date:  2001-10-12       Impact factor: 17.367

7.  The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.

Authors:  Pal Pacher; Lucas Liaudet; Francisco Garcia Soriano; Jon G Mabley; Eva Szabó; Csaba Szabó
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

8.  Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.

Authors:  Jon G Mabley; Eszter M Horváth; Kanneganti G K Murthy; Zsuzsanna Zsengellér; Anne Vaslin; Rita Benko; Márk Kollai; Csaba Szabó
Journal:  J Pharmacol Exp Ther       Date:  2005-08-03       Impact factor: 4.030

9.  Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice.

Authors:  Tomoya Mita; Aiko Otsuka; Kosuke Azuma; Toyoyoshi Uchida; Takeshi Ogihara; Yoshio Fujitani; Takahisa Hirose; Masako Mitsumata; Ryuzo Kawamori; Hirotaka Watada
Journal:  Biochem Biophys Res Commun       Date:  2007-05-04       Impact factor: 3.575

10.  Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy.

Authors:  Antonysunil Adaikalakoteswari; Mohan Rema; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Int J Biochem Cell Biol       Date:  2007-04-25       Impact factor: 5.085

View more
  43 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  A rat model of glycaemic variability.

Authors:  F Zaccardi; D Pitocco; G Ghirlanda
Journal:  Diabetologia       Date:  2009-05-14       Impact factor: 10.122

Review 3.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

4.  Puerarin may protect against Schwann cell damage induced by glucose fluctuation.

Authors:  Bing Xue; Lin Wang; Zhe Zhang; Rui Wang; Xin-Xin Xia; Ping-Ping Han; Li-Jun Cao; Yong-Hui Liu; Lian-Qing Sun
Journal:  J Nat Med       Date:  2017-02-08       Impact factor: 2.343

5.  Olaparib protects cardiomyocytes against oxidative stress and improves graft contractility during the early phase after heart transplantation in rats.

Authors:  Sevil Korkmaz-Icöz; Bartosz Szczesny; Michela Marcatti; Shiliang Li; Mihály Ruppert; Felix Lasitschka; Sivakkanan Loganathan; Csaba Szabó; Gábor Szabó
Journal:  Br J Pharmacol       Date:  2017-10-02       Impact factor: 8.739

6.  Influence of high blood glucose fluctuation on endothelial function of type 2 diabetes mellitus rats and effects of Panax Quinquefolius Saponin of stem and leaf.

Authors:  Jing-Shang Wang; Hui-Jun Yin; Chun-Yu Guo; Ye Huang; Cheng-Dong Xia; Qian Liu
Journal:  Chin J Integr Med       Date:  2012-05-19       Impact factor: 1.978

7.  Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function.

Authors:  Kunihiro Suzuki; Gabor Olah; Katalin Modis; Ciro Coletta; Gabriella Kulp; Domokos Gerö; Petra Szoleczky; Tuanjie Chang; Zongmin Zhou; Lingyun Wu; Rui Wang; Andreas Papapetropoulos; Csaba Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

8.  A pyridoindole antioxidant SMe1EC2 regulates contractility, relaxation ability, cation channel activity, and protein-carbonyl modifications in the aorta of young and old rats with or without diabetes mellitus.

Authors:  Arzu Şakul; Nuray Arı; Ruzenna Sotnikova; Gülgün Ozansoy; Çimen Karasu
Journal:  Geroscience       Date:  2018-07-27       Impact factor: 7.713

9.  High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.

Authors:  Federico Biscetti; Giuseppe Straface; Raimondo De Cristofaro; Stefano Lancellotti; Paola Rizzo; Vincenzo Arena; Egidio Stigliano; Giovanni Pecorini; Kensuke Egashira; Giulia De Angelis; Giovanni Ghirlanda; Andrea Flex
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

Review 10.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.